Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J. Joyner, Arturo Casadevall, Rickey E. Carter et al.|New England Journal of Medicine|2021Cited by 553
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J. Joyner, Arturo Casadevall, Rickey E. Carter et al.|Journal of Clinical Investigation|2020Cited by 485
Safety UpdateMichael J. Joyner, R. Scott Wright, Katelyn A. Bruno et al.|Mayo Clinic Proceedings|2020Cited by 432
Secondary Cancers after Chimeric Antigen Receptor T-Cell TherapyNicole Verdun, Peter Marks|New England Journal of Medicine|2024Cited by 257
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic LeukemiaR. Angelo de Claro, Richard Pazdur, Karen M. McGinn et al.|Clinical Cancer Research|2015Cited by 165